XOMA

XOMA Corp

XOMA, USA

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

https://www.xoma.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
XOMA
stock
XOMA

Lucid Capital Markets initiates coverage on XOMA stock with Buy rating Investing.com

Read more →
XOMA
stock
XOMA

CEO’s Bold Move: Massive Investment in Xoma Stock! TipRanks

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$70.6667

Analyst Picks

Strong Buy

2

Buy

1

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Earnings Ratio (P/E)

-

Low

41.51

Low ≥ 50

High ≤ 10

Price to Book Ratio (P/B)

-

Very High

5.39

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Medium

13.02 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Medium

5.34 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-4.35 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.44

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 92.31% of the total shares of XOMA Corp

1.

Bvf Inc

(21.4292%)

since

2025/06/30

2.

Morgan Stanley - Brokerage Accounts

(12.7813%)

since

2025/06/30

3.

FMR Inc

(8.9313%)

since

2025/06/30

4.

Vanguard Group Inc

(5.2848%)

since

2025/06/30

5.

BlackRock Inc

(4.8948%)

since

2025/06/30

6.

Vanguard Total Stock Mkt Idx Inv

(3.5512%)

since

2025/07/31

7.

Fidelity Advisor Equity Growth I

(2.4043%)

since

2025/07/31

8.

Morgan Stanley Insight I

(2.1855%)

since

2025/06/30

9.

Morgan Stanley Insight

(2.1855%)

since

2025/06/30

10.

Fidelity VIP Growth Initial

(2.1138%)

since

2025/07/31

11.

Opaleye Management Inc

(2.1103%)

since

2025/06/30

12.

Fidelity Contrafund

(2.1008%)

since

2025/07/31

13.

iShares Russell 2000 ETF

(1.7687%)

since

2025/08/31

14.

Geode Capital Management, LLC

(1.6844%)

since

2025/06/30

15.

Morgan Stanley Inst Inception I

(1.4971%)

since

2025/06/30

16.

Morgan Stanley Inception

(1.4971%)

since

2025/06/30

17.

Woodline Partners LP

(1.491%)

since

2025/06/30

18.

State Street Corp

(1.2697%)

since

2025/06/30

19.

Stonepine Capital Management Llc

(1.2587%)

since

2025/06/30

20.

Fidelity Growth Discovery

(1.2026%)

since

2025/07/31

21.

MS INVF Global Insight Z

(1.1551%)

since

2025/06/30

22.

TLS Advisors LLC

(0.9848%)

since

2025/06/30

23.

EQ/Morgan Stanley Small Cap Growth K

(0.9619%)

since

2025/07/31

24.

HighVista Strategies LLC

(0.9476%)

since

2025/06/30

25.

Northern Trust Corp

(0.7795%)

since

2025/06/30

26.

Fidelity Small Cap Index

(0.7707%)

since

2025/06/30

27.

Vanguard Institutional Extnd Mkt Idx Tr

(0.695%)

since

2025/07/31

28.

CM Management, LLC

(0.5295%)

since

2025/06/30

29.

iShares Russell 2000 Growth ETF

(0.5083%)

since

2025/08/31

30.

Bank of New York Mellon Corp

(0.4946%)

since

2025/06/30

31.

Fidelity Contrafund K6

(0.4765%)

since

2025/07/31

32.

Vanguard Russell 2000 ETF

(0.3698%)

since

2025/07/31

33.

Fidelity Extended Market Index

(0.3551%)

since

2025/07/31

34.

Pacific Select Large-Cap Growth I

(0.2772%)

since

2025/08/31

35.

Fidelity Advisor Series Equity Gr

(0.2706%)

since

2025/07/31

36.

RBF LLC

(0.2533%)

since

2025/06/30

37.

Dimensional Fund Advisors, Inc.

(0.231%)

since

2025/06/30

38.

Charles Schwab Investment Management Inc

(0.2182%)

since

2025/06/30

39.

Bridgeway Capital Management, LLC

(0.2167%)

since

2025/06/30

40.

OCCUDO QUANTITATIVE STRATEGIES LP

(0.1731%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

0.7

EPS Estimate

-0.085

EPS Difference

0.785

Surprise Percent

923.5294%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Weak Deep Value(3)
Defensive
Moderately Defensive(6)
Dividend
Weak Dividend Profile(2)
Economic Moat
Wide Moat Company(7)
GARP
Fair GARP(4.5)
Growth
Moderate Growth(3.5)
Momentum
Moderate Momentum(4)
Net Net
Not Undervalued (Net-Net)(1)
Quality
Moderate Quality(4.5)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.